North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Effect of Ovaleap® on the Pregnancy Rate and User-friendliness of the Ovaleap®-Pen
- Study Title
- A Study to Evaluate the Effect of Ovaleapֲ® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleapֲ®-Pen.
- Teva Identifier
- XM17-WH-40103
- ClinicalTrials.gov Identifier
- NCT02809989
- Study Status
- Completed
- Trial Condition(s)
- Pregnancy Rate | Oocytes
- Interventions
- Drug: Ovaleapֲ®
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age Range
- 18 Years to 40 Years
- Trial Duration
- 03/31/2016 - 03/13/2018
